Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial

Am J Respir Crit Care Med. 2022 Sep 15;206(6):780-783. doi: 10.1164/rccm.202203-0608LE.

Authors

Yin Yao¹, Ao Huang¹, Yi-Ke Deng¹, Yan Liu¹, Hong-Yu Zhu¹, Nan Wang¹, Zhe-Zheng Wang¹, Rong-Fei Zhu¹, Di Yu², Zheng Liu¹

Affiliations

¹ Tongji Hospital affiliated to Huazhong University of Science and Technology Wuhan, China.
² The University of Queensland Brisbane, Australia.

No abstract available

Publication types

Letter
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Allergens
COVID-19 Vaccines
COVID-19*
Desensitization, Immunologic
Humans
Immunity
Rhinitis, Allergic* / therapy
SARS-CoV-2

Substances

Allergens
COVID-19 Vaccines

Associated data

ClinicalTrials.gov/NCT05009134